Does Mounjaro Raise Blood Pressure — or Does It Help?

What SURMOUNT-1 actually recorded on blood pressure

The largest tirzepatide weight-loss trial randomised 2,539 adults with obesity and no diabetes, following them for 72 weeks. By the end, participants taking the 15mg dose had lost around 20–21% of their body weight on average, and systolic blood pressure fell alongside it, typically by several mmHg from a baseline that was already within a normal-to-mild range. The SURMOUNT-1 paper, published in the New England Journal of Medicine, reported these cardiovascular measurements as secondary endpoints, and none of the tirzepatide arms showed a mean rise in systolic pressure. So the short answer to whether Mounjaro raises blood pressure: for the average trial participant, it did the opposite.

Weight and blood pressure are tightly coupled in the human body. Fat tissue, particularly visceral fat, drives hormonal and mechanical changes that push pressure up. When weight falls, those pressures ease. Much of the blood-pressure benefit seen with Mounjaro is thought to follow from the weight loss itself rather than from any direct action on blood vessels, though researchers continue to study whether GIP and GLP-1 receptor activation has its own vascular effects.

Heart rate: the one reading that can tick upward

There is a nuance worth knowing. Some people taking GLP-1 and dual-agonist medicines notice a modest rise in resting heart rate, typically in the range of two to four beats per minute on average across trials. This is not the same as raised blood pressure, and for most people it is clinically insignificant. The NHS medicines page for tirzepatide lists this as a known effect to be aware of rather than a reason to avoid the medicine.

For anyone with a history of rapid or irregular heart rhythms, this is a conversation to have with your prescriber before starting. The prescriber review at nume (carried out by a real GPhC-registered clinician, not automated software) includes a cardiovascular history check precisely so this can be weighed individually. A slightly faster resting pulse in the context of a five- or six-kilogram blood-pressure reduction from weight loss is a very different trade-off for each person.

If you are already on antihypertensive medicines, bring that to your prescriber's attention. As blood pressure falls with weight loss, your existing medication dose may need adjusting, underdosing becomes a risk if treatment is not reviewed alongside your progress. Our broader guide to how Mounjaro affects blood pressure covers the monitoring picture in more detail.

What this means if you have hypertension and are considering Mounjaro

High blood pressure is one of the weight-related conditions that can affect eligibility for Mounjaro under its UK licence. Adults with a BMI of 27 or above who have hypertension alongside their weight may qualify for treatment, subject to clinical assessment. This means the medicine is specifically considered for people whose cardiovascular picture is already affected by excess weight, not something they need to be cautious about just because they have high blood pressure.

A practical checking habit: before your consultation, take your blood pressure at a local pharmacy or with a home monitor and note the reading. A single figure gives your prescriber a useful baseline, particularly if you are on antihypertensives. It takes under a minute. Pharmacies across the UK offer free spot checks, and most supermarket pharmacies have a self-service machine. Our page on how Mounjaro may help with blood pressure sets out what the evidence suggests for people in this position.

It is also worth knowing that NICE's recommendation for tirzepatide (TA1026, recommendations chapter) lists cardiovascular disease as one of five qualifying conditions for NHS access at relevant BMI thresholds. Hypertension is not separately listed among those five, but weight-related cardiovascular risk sits at the centre of why this medicine was recommended at all. For a fuller picture of tirzepatide's clinical profile, our tirzepatide overview covers the evidence base in one place.

When to speak to a doctor promptly

Starting any new medicine warrants paying attention to how your body responds. If you notice unexplained headaches, visual changes, chest tightness or palpitations in the weeks after beginning Mounjaro, contact your GP or prescriber promptly. These are not listed as common side effects of tirzepatide, but they are symptoms worth investigating regardless of what medication you are on.

Readers who want to understand the evidence for tirzepatide having an actively lowering effect on blood pressure over time can find a detailed discussion on our does Mounjaro lower blood pressure page. If you have been told your blood pressure runs on the low side, the considerations are different and worth reading separately on our Mounjaro and low blood pressure page.

For questions about how Mounjaro fits your specific health background, the right place to start is a clinical consultation, and people often have practical lifestyle questions too, such as whether you can have a tattoo while taking Mounjaro. Check your eligibility with our prescribers at our weight-loss treatments page, the consultation is free, and a GPhC-registered clinician reads every submission personally, the same day.